Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001108205-25-000065
Filing Date
2025-05-22
Accepted
2025-05-22 16:13:02
Documents
1
Period of Report
2025-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1747944773.html 4  
1 FORM 4 wk-form4_1747944773.xml 4 4724
  Complete submission text file 0001108205-25-000065.txt   6230
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Issuer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE 5TH FLOOR CAMBRIDGE MA 02140
Business Address
Duvall Diantha (Reporting) CIK: 0001696784 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30347 | Film No.: 25977253